Dyne Therapeutics, Inc.

NASDAQ

DYN

Stock

Yield per half year: -2.37%
Dividend yield: 0%
Sector: Healthcare

Compare companies

Download the report:

Excel

Word

PDF

	Dyne Therapeutics, Inc.	Gilead Sciences	Amgen
Capitalization
Price	14.44	105.93	280.35
Price priv.
Number of shares, million	94.14	1255	541
Capitalization, billion	0.6255	94.55	140.05
EBITDA, billion	-0.3152	4.43	13.36
EV, billion	1.81	132.64	189.13
Profit and loss report
Net profit, billion	-0.3174	0.48	4.09
Revenue, billion	0	28.75	33.42
EPS	-3.37	0.3825	7.56
Balance
Assets, billion	0.6912	59	91.84
Debt, billion	0.024	26.71	60.1
Balance cost, billion	0.6298	19.33	5.88
Cash, billion	0.4354	9.99	11.97
Coefficients
Dividend yield, %	0	3.17	2.94
Dividend	0	3.12	9.26
Dividend yield priv., %	0	0	0
Dividend priv.	0	0	0
Dividends/profit, %	0	816.25	118.14
P/S	0	4.03	4.22
P/BV	3.52	6.02	23.99
P/E	0	241.51	34.48
Ev/Ebitda	-5.73	29.92	14.16
Debt/Ebitda	-0.0761	6.02	4.5
Efficiency
ROE	-88.03	2.28	67.55
ROA	-74.14	0.7926	4.33
ROIC	-36.69	11.06	17
Ebitda margin	0	15.42	39.96
Net margin	0	1.67	12.24
Momentum
1 week, price changes	-1.77 %	-2.37 %	-3.1 %
1 month, price changes	+21.34 %	-2.83 %	-2.32 %
3 months, price changes	+91.26 %	+0.3981 %	+0.7004 %
6 months, price changes	-2.37 %	+1.78 %	-3.71 %
1 year, price changes	-67.2 %	+27.92 %	-15.67 %
3 years, price changes	+23.74 %	+66.11 %	+24.04 %
5 years, price changes		+63.9 %	+12.95 %
10 years, price changes		+47.93 %	+86.42 %

More data >>

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe